Automated Sampling of Microphysiological Systems for in situ Bioanalysis

To study the effects of deep space stressors on organ and tissue systems, flight instrumentation consisting of autonomous microphsiological systems hardware with bioanalysis capability is attractive.  Our objective is to deliver an integrated flight-compatible and autonomous MPS fluidic instrumentation and flight-compatible and autonomous magnetic electrochemical enzyme linked immunosorbent assay (Mag-EC ELISA).  The coupling of these technologies will enable in situ studies of the effects of stressors associated with long term space habitation.

To study the effects of deep space stressors on organ and tissue systems during flight and without human or animal subjects, autonomous MPS with in situ bioanalysis is required.  This project will accelerate the development of MPS hardware towards flight, enabling the study of deep space stressors on organ and tissue systems.  

This is a mature technology (TRL 7+) — the realistic path in is usually NASA's Technology Transfer Program: licensing an existing NASA patent, or a Space Act Agreement to use NASA facilities/expertise directly. NASA also runs a startup licensing program with no upfront fee for companies formed to commercialize a specific NASA technology.

None of these are guaranteed paths for this specific project — TechPort itself doesn't have an "apply" button. Reaching out to the contact(s) above with a specific question is usually the fastest way to find out what's actually open.